Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 387.00
+0.60 (0.16%)
Jun 12, 2026, 4:59 PM CET
Novozymes Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Novozymes stock has a consensus rating of "Buy" and an average price target of kr 460.94. The average 1-year stock price forecast is 19.11% higher than the current stock price, while the lowest is kr 362.00 (-6.46%) and the highest is kr 552.00 (+42.64%).
Price Target: kr 460.94 (+19.11%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novozymes stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 10 | 10 | 11 | 11 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 5 | 5 | 3 | 3 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 17 | 17 | 17 | 17 |
Financial Forecast
Revenue This Year
4.43B
from 4.16B
Increased by 6.46%
Revenue Next Year
4.75B
from 4.43B
Increased by 7.25%
EPS This Year
2.13
from 1.99
Increased by 7.19%
EPS Next Year
2.34
from 2.13
Increased by 9.61%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.5B | ||
| Avg | 4.4B | ||
| Low | 4.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.0% | ||
| Avg | 6.5% | ||
| Low | 4.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.24 | ||
| Avg | 2.13 | ||
| Low | 2.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.6% | ||
| Avg | 7.2% | ||
| Low | 2.5% |